CT-Based Radiomics Combined with Genomics may Predict Survival in Esophageal Cancer Patients Receiving Definitive Chemoradiotherapy

被引：0
|
作者：
Cui, J. [1 ]
Li, L. [1 ]
Yuan, S. [2 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong First Med Univ, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2634
引用
收藏
页码：E290 / E290
页数：1
相关论文
共 50 条
  • [1] Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy
    Jinfeng Cui
    Li Li
    Ning Liu
    Wenhong Hou
    Yinjun Dong
    Fengchang Yang
    Shouhui Zhu
    Jun Li
    Shuanghu Yuan
    Biomarker Research, 11
  • [2] Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy
    Cui, Jinfeng
    Li, Li
    Liu, Ning
    Hou, Wenhong
    Dong, Yinjun
    Yang, Fengchang
    Zhu, Shouhui
    Li, Jun
    Yuan, Shuanghu
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [3] CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy
    Jinfeng Cui
    Dexian Zhang
    Yongsheng Gao
    Jinghao Duan
    Lulu Wang
    Li Li
    Shuanghu Yuan
    Insights into Imaging, 15
  • [4] CT-based radiomics combined with hematologic parameters for survival prediction in locally advanced esophageal cancer patients receiving definitive chemoradiotherapy
    Cui, Jinfeng
    Zhang, Dexian
    Gao, Yongsheng
    Duan, Jinghao
    Wang, Lulu
    Li, Li
    Yuan, Shuanghu
    INSIGHTS INTO IMAGING, 2024, 15 (01)
  • [5] CT-Based Radiomics Nomogram may predict Local Recurrence-free Survival in Esophageal Squamous Cell Carcinoma Patients Receiving Definitive Chemoradiotherapy: A Multicenter Study
    Zhao, L.
    Zhang, W.
    Gong, J.
    Liao, Y.
    Yin, Y.
    Qin, W.
    Shi, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E587 - E587
  • [6] CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study
    Gong, Jie
    Zhang, Wencheng
    Huang, Wei
    Liao, Ye
    Yin, Yutian
    Shi, Mei
    Qin, Wei
    Zhao, Lina
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : 8 - 15
  • [7] Development and Validation of a Radiomics-Based Model to Predict Overall Survival after Definitive Chemoradiotherapy in Patients with Esophageal Cancer
    Cui, J.
    Li, L.
    Yuan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E290 - E291
  • [8] A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study
    Gong, Jie
    Lu, Jianchao
    Zhang, Wencheng
    Huang, Wei
    Li, Jie
    Yang, Zhi
    Meng, Fan
    Sun, Hongfei
    Zhao, Lina
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [9] CT-Based Radiomics and Genomics Analysis for Survival Prediction in Stage Ill Unresectable Non -Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy Following with Immunotherapy
    Geng, Y.
    Yin, T.
    Li, Y.
    Yu, J.
    Teng, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E71 - E72
  • [10] Multi-Centered Pre-Treatment CT-Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive Chemoradiotherapy
    Yu, Nuo
    Ge, Xiaolin
    Zuo, Lijing
    Cao, Ying
    Wang, Peipei
    Liu, Wenyang
    Deng, Lei
    Zhang, Tao
    Wang, Wenqing
    Wang, Jianyang
    Lv, Jima
    Xiao, Zefen
    Feng, Qinfu
    Zhou, Zongmei
    Bi, Nan
    Zhang, Wencheng
    Wang, Xin
    CANCERS, 2025, 17 (01)
12345